
DoubleRainbow Biosciences Stock
DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry.
Sign up today and learn more about DoubleRainbow Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About DoubleRainbow Biosciences Stock
DoubleRainbow Biosciences develops transformative technologies to unleash the power of chemistry from the natural world to benefit people’s lives. Rooted in the mechanistic understanding of specialized metabolic systems in plants and other organisms, we devise novel biosynthetic strategies that provide sustainable access to high-value natural products of medicinal or industrial significance. Inspired by the evolutionary principles underlying natural metabolic systems, it further expands the chemical space beyond what nature offers. Leveraging ancient wisdom distilled into the world’s traditional herbal medicines and a deep knowledge base of modern disease biology, it develops nature-inspired new medicines for treating human diseases.
Funding History
August 2018 | $2.0M |
---|---|
April 2019 | $3.0M |
October 2020 | $10.0M |
Management
Founder
Tian Xu
Chief of Staff and Senior Director of Business Development
Kevin O’Driscoll
Chief Business Officer
Jamie Jones
Chief Medical Officer
Holly Schachner
Founder
Jing-Ke Weng
Press
globenewswire - Aug, 22 2022
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeuticsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase